On November 12, Aehr Test fell 5.24% Overnight, trading at $62.33/share, with turnover of $1.06 million.
The move came after the market had been actively trading the company’s stronger-than-expected quarterly results, higher full-year revenue outlook, and AI chip testing order progress, but the marginal boost from those positives appeared to fade following the prior session’s sharp rally.
Previously disclosed results showed adjusted EPS of $0.28 versus expectations of $0.11 and revenue of $33.007 million versus $27.072 million expected. The company also reported backlog of $100.9 million and highlighted deployment progress with a major AI accelerator customer, including a fully configured FOX-XP wafer-level burn-in system planned for installation at a partner facility in Taiwan in early 2027, alongside an earlier approximately $6 million follow-on AI chip testing equipment order.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments